Target Audience

Family Physicians, General Practitioners, Internists, Cardiologists, Nurses, Residents, and Other Health Care Professionals.

Learning Objectives

At the end of this learning activity, the participants will be able to:

• Discuss novel therapies for cardiovascular disease.
• Identify the role for new interventional therapies for structural heart disease.
• Discuss special considerations in the treatment of cardiovascular disease in specific populations.

Accreditation Statements

McMaster University, Continuing Professional Development Program (CPD) is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME) to provide CFPC Mainpro+ and RCPSC Maintenance of Certification (MOC) study credits for Continuing Medical Education.

This one-credit-per-hour Group-Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by the McMaster University Continuing Professional Development Program for up to 10.75 Mainpro+ credits. (Day 1 = 6.5 and Day 2 = 4.25)

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by McMaster University Continuing Professional Development Program. You may claim a maximum of 10.75 MOC Section 1 hours (credits are automatically calculated). (Day 1 = 6.5 and Day 2 = 4.25)

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Each attendee should only claim the hours they attended.